您的位置: 首页 > 农业专利 > 详情页

SIRNA FOR INHIBITION OF HIF1A EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME
专利权人:
SAMYANG BIOPHARMACEUTICALS CORPORATION
发明人:
KIM, SUN-OK,KIM, SANG-HEE,CHO, EUN-AH,IN, CHANG-HOON
申请号:
CA2823138
公开号:
CA2823138A1
申请日:
2011.12.29
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
Disclosed are small interfering RNA (siRNA) that complementarily binds to a base sequence of Hif1a mRNA transcript, thereby inhibiting expression of Hif1a without inducing immune responses, and a use of the siRNA for prevention and/or treatment of cancer. Since Hif1a is commonly overexpressed in almost all cancer cells, the siRNA that complementarily binds to Hif1a-encoding mRNA may inhibit expression of Hif1a through RNA-mediated interference (RNAi), thereby inhibiting proliferation and metastasis of cancer cells, and thus, the siRNA may be useful as an anticancer agent.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充